A carregar...
Learning from the past for TB drug discovery in the future
Tuberculosis drug discovery has shifted in recent years from a primarily target-based approach to one that uses phenotypic high-throughput screens. As examples of this, through our EU-funded FP7 collaborations, New Medicines for Tuberculosis was target-based and our more-recent More Medicines for Tu...
Na minha lista:
| Publicado no: | Drug Discov Today |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362327/ https://ncbi.nlm.nih.gov/pubmed/27717850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2016.09.025 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|